UCAP(SH:688228)2025-04-25 11:00Financial Performance - The company's operating revenue for Q1 2025 was ¥60,297,628.73, a decrease of 31.32% compared to ¥87,791,341.28 in the same period last year[4] - Net profit attributable to shareholders was ¥732,234.55, an increase of 156.77% from ¥285,176.07 year-on-year[4] - Net profit for Q1 2025 was a loss of CNY 909,176.69, an improvement from a loss of CNY 8,172,935.90 in Q1 2024[18] - Basic and diluted earnings per share were both ¥0.01, reflecting the increase in net profit attributable to shareholders[4] - The weighted average return on net assets increased by 0.04 percentage points to 0.06% due to the growth in net profit attributable to shareholders[4] Cash Flow - The net cash flow from operating activities was -¥45,771,472.08, improving from -¥129,440,072.18 in the previous year[4] - Cash flow from operating activities in Q1 2025 was CNY 129,917,932.09, an increase from CNY 103,239,021.52 in Q1 2024, representing a growth of 25.0%[22] - The company reported a total cash outflow from operating activities of 185,831,682.98, compared to 239,405,538.11 in the previous period[23] - The net increase in cash and cash equivalents was -20,992,477.50, an improvement from -136,427,614.67 in the prior period[24] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,940,275,336.30, a decrease of 1.73% from ¥1,974,500,221.78 at the end of the previous year[5] - Total current assets decreased from 1,369,062,820.30 RMB on December 31, 2024, to 1,305,405,322.10 RMB on March 31, 2025, a decline of approximately 4.66%[13] - Total liabilities decreased to CNY 512,938,808.93 from CNY 546,514,690.81, indicating a reduction of 6.1%[15] - Non-current assets totaled CNY 634,870,014.20, up from CNY 605,437,401.48, showing an increase of 4.0%[15] Research and Development - Research and development expenses totaled ¥21,021,696.75, accounting for 34.86% of operating revenue, an increase of 8.59 percentage points from 26.27%[5] - The company continues to focus on R&D investment despite the revenue decline, indicating a commitment to innovation and future growth[5] - Research and development expenses for Q1 2025 were CNY 16,244,291.71, compared to CNY 18,663,135.47 in Q1 2024, reflecting a decrease of 12.9%[18] Shareholder Information - Total number of common shareholders at the end of the reporting period is 7,727[10] - The largest shareholder, Wang Min, holds 18,552,800 shares, accounting for 27.48% of total shares[10] - The company has not reported any changes in the top 10 shareholders or their shareholding due to securities lending activities[12] Non-Recurring Items - Non-recurring gains and losses amounted to ¥3,008,673.38, primarily driven by an increase in non-operating income[7] Revenue Decline Factors - The decline in operating revenue was mainly attributed to a decrease in income from AI large model and computing power business[8] Cash and Cash Equivalents - Cash and cash equivalents decreased from 248,254,749.44 RMB to 222,667,905.84 RMB, a decrease of about 10.3%[13] - The total cash and cash equivalents at the end of the period were 219,387,333.66, down from 491,588,485.81 at the beginning[24]